Logo Integer Holdings Corporation

Integer Holdings Corporation (ITGR) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Integer Holdings Corporation · Health Care · ref. ETF XLV · 66 calls · price $125.3
🔔Price alertsCreate an alert →
What the company does: Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.

📈 Integer Holdings Corporation (ITGR) stock price

$125.3+16.7% over range
Aug 28, 25low $63.32 · high $126.07Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
13% recommend buying · 8 analysts
📊 JPI status : Integer Holdings Corporation has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 ITGR price target & analyst consensusprice $125

The price target · all analysts combined (6 targets)
Highest target · 2 firms of 6$127+1.4%
Median target · of 6 targets$112-10.6%
Lowest target · 1 firm of 6$96-23.4%
Current price$125.3
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 233% $127
Below 467% $96 ↔ $115
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy113%
Hold788%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Integer Holdings Corporation? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on ITGR

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Keybanc  59% +13.7% 22
Argus Research  50% +8.0% 2
Piper Sandler  50% -2.9% 2
Benchmark  45% -6.1% 11
Truist Securities  12% -25.0% 8
B of A Securities  0% -10.2% 2
Raymond James  0% -21.9% 3

📊 What $1,000 invested in Integer Holdings Corporation would be worth › open the full page

In short — $1,000 invested in Integer Holdings Corporation 10 years ago would be worth $1,950 today, i.e. +7%/yr on average. Best year: 2018 (+68%), worst: 2025 (-41%). Price performance, excluding dividends.

If I'd invested $1,000 in Integer Holdings Corporation

InvestmentWorth todayGain
1 years ago$704-30%
3 years ago$1,363+36%
5 years ago$1,149+15%
→ See Integer Holdings Corporation's full return history + gain calculator

Return by year (Integer Holdings Corporation)

YearReturn$1,000 invested at year start
2026 (YTD)+19%$1,190 (+19%)
2025-41%$704 (-30%)
2024+34%$942 (-6%)
→ See Integer Holdings Corporation's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Integer Holdings Corporation

Loading news…

📋 All analyst calls on ITGR

Benchmark 
Aug 14, 26
■ Hold neutral · not a buy
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
in progress (365j)
matures : Aug 14, 27
Oppenheimer 
Aug 4, 26
■ Perform neutral · not a buy
🎯 on ITGR : no call matured yet · 📊 on Health : 47.3% · +6.3% (93 calls)
in progress (365j)
matures : Aug 4, 27
■ Hold neutral · not a buy · 🎯$127
Price at call : $125 — gap to target +2%
Today : $125.3 — gap to target +1%
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Aug 4, 27
Wells Fargo 
Aug 4, 26
■ Equal-Weight neutral · not a buy · 🎯$127
Price at call : $125.05 — gap to target +2%
Today : $125.3 — gap to target +1%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Aug 4, 27
■ Hold neutral · not a buy
🎯 on ITGR : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Aug 4, 27
Keybanc 
Aug 3, 26
■ Sector Weight neutral · not a buy
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Aug 3, 27
▲ Buy · 🎯$112
Price at call : $96.56 — upside +16%
Today : $125.3 — upside -11%
🎯 on ITGR : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jul 22, 27
▲ Buy · 🎯$110
Price at call : $95.42 — upside +15%
Today : $125.3 — upside -12%
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Jul 16, 27
See the other 58 calls, newest to oldest
Citigroup 
Jul 8, 26
■ Neutral neutral · not a buy · 🎯$96
Price at call : $91.95 — gap to target +4%
Today : $125.3 — gap to target -23%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Jul 8, 27
Citigroup 
May 28, 26
■ Neutral neutral · not a buy · 🎯$92
Price at call : $89.38 — gap to target +3%
Today : $125.3 — gap to target -27%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : May 28, 27
Oppenheimer 
May 13, 26
▲ Outperform · 🎯$115
Price at call : $89.39 — upside +29%
Today : $125.3 — upside -8%
🎯 on ITGR : no call matured yet · 📊 on Health : 47.3% · +6.3% (93 calls)
in progress (365j)
matures : May 13, 27
Citigroup 
May 1, 26
■ Neutral neutral · not a buy · 🎯$89
Price at call : $83.95 — gap to target +6%
Today : $125.3 — gap to target -29%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : May 1, 27
Piper Sandler 
May 1, 26
▲ Overweight · 🎯$97
Price at call : $83.95 — upside +16%
Today : $125.3 — upside -23%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : May 1, 27
Citigroup 
Feb 20, 26
■ Neutral neutral · not a buy · 🎯$92
Price at call : $85.76 — gap to target +7%
Today : $125.3 — gap to target -27%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Feb 20, 27
Wells Fargo 
Feb 20, 26
■ Equal-Weight neutral · not a buy · 🎯$84
Price at call : $85.76 — gap to target -2%
Today : $125.3 — gap to target -33%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 20, 27
Benchmark 
Feb 20, 26
▲ Buy · 🎯$95
Price at call : $85.76 — upside +11%
Today : $125.3 — upside -24%
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
in progress (365j)
matures : Feb 20, 27
▲ Buy · 🎯$97
Price at call : $85.76 — upside +13%
Today : $125.3 — upside -23%
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Feb 20, 27
▲ Buy · 🎯$95
Price at call : $78.52 — upside +21%
Today : $125.3 — upside -24%
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Dec 18, 26
Citigroup 
Dec 11, 25
■ Neutral neutral · not a buy · 🎯$75
Price at call : $72.72 — gap to target +3%
Today : $125.3 — gap to target -40%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Dec 11, 26
▲ Buy · 🎯$86
Price at call : $71.43 — upside +20%
Today : $125.3 — upside -31%
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Nov 24, 26
Citigroup 
Nov 3, 25
■ Neutral neutral · not a buy · 🎯$69
Price at call : $68.61 — gap to target +1%
Today : $125.3 — gap to target -45%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Nov 3, 26
▲ Buy · 🎯$88
Price at call : $70.2 — upside +25%
Today : $125.3 — upside -30%
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Oct 24, 26
Raymond James 
Oct 24, 25
▲ Outperform · 🎯$95
Price at call : $70.2 — upside +35%
Today : $125.3 — upside -24%
🎯 on ITGR : 0% (3 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
in progress (365j)
matures : Oct 24, 26
Piper Sandler 
Oct 24, 25
▲ Overweight · 🎯$82
Price at call : $70.2 — upside +17%
Today : $125.3 — upside -35%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Oct 24, 26
Benchmark 
Oct 24, 25
■ Hold neutral · not a buy
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
in progress (365j)
matures : Oct 24, 26
Keybanc 
Oct 24, 25
▲ Overweight · 🎯$93
Price at call : $72.91 — upside +28%
Today : $125.3 — upside -26%
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Oct 24, 26
Wells Fargo 
Oct 24, 25
■ Equal-Weight neutral · not a buy · 🎯$80
Price at call : $72.91 — gap to target +10%
Today : $125.3 — gap to target -36%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Oct 24, 26
Citigroup 
Oct 24, 25
■ Neutral neutral · not a buy · 🎯$77
Price at call : $72.91 — gap to target +6%
Today : $125.3 — gap to target -39%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Oct 24, 26
Keybanc 
Oct 21, 25
▲ Overweight · 🎯$133
Price at call : $107.94 — upside +23%
Today : $125.3 — upside +6%
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Oct 21, 26
▲ Buy · 🎯$121
Price at call : $103.12 — upside +17%
Today : $125.3 — upside -3%
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Oct 15, 26
Raymond James 
Jul 25, 25
▲ Outperform · 🎯$143
Price at call : $108.14 — upside +32%
Today : $125.3 — upside +14%
Expected +32% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 0% (3 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-8.1%
stock -8% · XLV +21%
matured Jul 25, 26
▲ Buy · 🎯$137
Price at call : $108.14 — upside +27%
Today : $125.3 — upside +9%
Expected +27% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-8.1%
stock -8% · XLV +21%
matured Jul 25, 26
Wells Fargo 
Jul 25, 25
▲ Overweight · 🎯$132
Price at call : $108.14 — upside +22%
Today : $125.3 — upside +5%
Expected +22% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 37.5% · +1.0% (104 calls)
-8.1%
stock -8% · XLV +21%
matured Jul 25, 26
Citigroup 
May 22, 25
▲ Buy · 🎯$140
Price at call : $118.16 — upside +18%
Today : $125.3 — upside +12%
Expected +18% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
-24.4%
stock -24% · XLV +15%
matured May 22, 26
▲ Buy · 🎯$150
Price at call : $126.93 — upside +18%
Today : $125.3 — upside +20%
Expected +18% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-34.1%
stock -34% · XLV +3%
matured Apr 28, 26
Raymond James 
Apr 25, 25
▲ Outperform · 🎯$150
Price at call : $122.78 — upside +22%
Today : $125.3 — upside +20%
Expected +22% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 0% (3 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-30.5%
stock -30% · XLV +4%
matured Apr 25, 26
Benchmark 
Apr 25, 25
▲ Buy · 🎯$140
Price at call : $122.78 — upside +14%
Today : $125.3 — upside +12%
Expected +14% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-30.5%
stock -30% · XLV +4%
matured Apr 25, 26
Keybanc 
Apr 21, 25
▲ Overweight · 🎯$145
Price at call : $117.98 — upside +23%
Today : $125.3 — upside +16%
Expected +23% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-27.8%
stock -28% · XLV +8%
matured Apr 21, 26
▲ Buy · 🎯$140
Price at call : $117.97 — upside +19%
Today : $125.3 — upside +12%
Expected +19% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-25.6%
stock -26% · XLV +7%
matured Apr 11, 26
Raymond James 
Mar 28, 25
▲ Outperform · 🎯$145
Price at call : $116.95 — upside +24%
Today : $125.3 — upside +16%
Expected +24% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 0% (3 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-27.2%
stock -27% · XLV -0%
matured Mar 28, 26
Benchmark 
Feb 21, 25
▲ Buy · 🎯$150
Price at call : $126.98 — upside +18%
Today : $125.3 — upside +20%
Expected +18% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-32.5%
stock -32% · XLV +7%
matured Feb 21, 26
Citigroup 
Feb 20, 25
■ Neutral neutral · not a buy · 🎯$151
Price at call : $129.87 — gap to target +16%
Today : $125.3 — gap to target +21%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Feb 20, 26
Keybanc 
Jan 24, 25
▲ Overweight · 🎯$154
Price at call : $143.13 — upside +8%
Today : $125.3 — upside +23%
Expected +8% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-39.8%
stock -40% · XLV +7%
matured Jan 24, 26
Citigroup 
Dec 11, 24
■ Neutral neutral · not a buy · 🎯$145
Price at call : $139.29 — gap to target +4%
Today : $125.3 — gap to target +16%
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Dec 11, 25
▲ Buy · 🎯$163
Price at call : $140.62 — upside +16%
Today : $125.3 — upside +30%
Expected +16% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-48.6%
stock -49% · XLV +8%
matured Dec 11, 25
Piper Sandler 
Oct 25, 24
▲ Overweight · 🎯$140
Price at call : $127.93 — upside +9%
Today : $125.3 — upside +12%
Expected +9% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 0% (1 call matured) · 📊 on Health : 45.8% · +6.9% (249 calls)
-45.1%
stock -45% · XLV -2%
matured Oct 25, 25
▲ Buy · 🎯$147
Price at call : $127.93 — upside +15%
Today : $125.3 — upside +17%
Expected +15% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 0% (5 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-45.1%
stock -45% · XLV -2%
matured Oct 25, 25
Benchmark 
Oct 25, 24
▲ Buy · 🎯$140
Price at call : $127.93 — upside +9%
Today : $125.3 — upside +12%
Expected +9% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-45.1%
stock -45% · XLV -2%
matured Oct 25, 25
Benchmark 
Oct 21, 24
▲ Buy · 🎯$140
Price at call : $127.8 — upside +10%
Today : $125.3 — upside +12%
Expected +10% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-15.5%
stock -16% · XLV -4%
matured Oct 21, 25
Keybanc 
Oct 15, 24
▲ Overweight · 🎯$144
Price at call : $131.49 — upside +10%
Today : $125.3 — upside +15%
Expected +10% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-21.1%
stock -21% · XLV -7%
matured Oct 15, 25
Benchmark 
Oct 2, 24
▲ Buy · 🎯$130
Price at call : $125.78 — upside +3%
Today : $125.3 — upside +4%
Expected +3% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-16.5%
stock -16% · XLV -4%
matured Oct 2, 25
Benchmark 
Aug 2, 24
▲ Buy · 🎯$130
Price at call : $110.25 — upside +18%
Today : $125.3 — upside +4%
Expected +18% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
-3.1%
stock -3% · XLV -9%
matured Aug 2, 25
Benchmark 
May 10, 24
▲ Buy · 🎯$130
Price at call : $112.69 — upside +15%
Today : $125.3 — upside +4%
Expected +15% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+7.1%
stock +7% · XLV -5%
matured May 10, 25
Benchmark 
Apr 26, 24
▲ Buy · 🎯$130
Price at call : $114.57 — upside +13%
Today : $125.3 — upside +4%
Expected +13% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+7.2%
stock +7% · XLV -1%
matured Apr 26, 25
Keybanc 
Apr 9, 24
▲ Overweight · 🎯$139
Price at call : $118.99 — upside +17%
Today : $125.3 — upside +11%
Expected +17% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-2.2%
stock -2% · XLV -3%
matured Apr 9, 25
Benchmark 
Mar 28, 24
▲ Buy · 🎯$130
Price at call : $115.99 — upside +12%
Today : $125.3 — upside +4%
Expected +12% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+1.7%
stock +2% · XLV -0%
matured Mar 28, 25
Keybanc 
Feb 16, 24
▲ Overweight · 🎯$123
Price at call : $99.39 — upside +24%
Today : $125.3 — upside -2%
Expected +24% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
+42.0%
stock +42% · XLV -1%
matured Feb 15, 25
Keybanc 
Feb 6, 24
▲ Overweight · 🎯$125
Price at call : $105.37 — upside +19%
Today : $125.3 — upside -0%
Expected +19% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
+35.1%
stock +35% · XLV +3%
matured Feb 5, 25
Benchmark 
Jul 28, 23
▲ Buy · 🎯$105
Price at call : $92.48 — upside +14%
Today : $125.3 — upside -16%
Expected +14% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+29.5%
stock +29% · XLV +12%
matured Jul 27, 24
Keybanc 
Jul 28, 23
▲ Overweight · 🎯$105
Price at call : $91.75 — upside +14%
Today : $125.3 — upside -16%
Expected +14% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
+30.5%
stock +31% · XLV +11%
matured Jul 27, 24
Keybanc 
Apr 28, 23
▲ Overweight · 🎯$96
Price at call : $82.35 — upside +17%
Today : $125.3 — upside -23%
Expected +17% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
+39.1%
stock +39% · XLV +5%
matured Apr 27, 24
Keybanc 
Feb 9, 23
▲ Overweight · 🎯$86
Price at call : $70.84 — upside +21%
Today : $125.3 — upside -31%
Expected +21% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
+49.2%
stock +49% · XLV +10%
matured Feb 9, 24
Keybanc 
Oct 6, 22
▲ Overweight · 🎯$84
Price at call : $55.28 — upside +52%
Today : $125.3 — upside -33%
Expected +52% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
+42.9%
stock +43% · XLV +4%
matured Oct 6, 23
Keybanc 
Jul 29, 22
▲ Overweight · 🎯$97
Price at call : $69.89 — upside +39%
Today : $125.3 — upside -23%
Expected +39% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
+32.3%
stock +32% · XLV +1%
matured Jul 29, 23
Keybanc 
Mar 1, 22
▲ Overweight · 🎯$109
Price at call : $80.78 — upside +35%
Today : $125.3 — upside -13%
Expected +35% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on ITGR : 58% (12 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-5.3%
stock -5% · XLV -2%
matured Mar 1, 23
Benchmark 
May 14, 20
▲ Buy · 🎯$105
Price at call : $71.66 — upside +47%
Today : $125.3 — upside -16%
Expected +47% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on ITGR : 45% (11 calls matureds) · 📊 on Health : 48.5% · +3.8% (68 calls)
+30.6%
stock +31% · XLV +24%
matured May 14, 21

Frequently asked questions

Should I buy Integer Holdings Corporation stock?

This isn't buy advice. For Integer Holdings Corporation, the analyst consensus is "Hold", with an average price target of $112 (-11% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 59% of the time (22 calls tracked on Integer Holdings Corporation). We show the numbers — you decide.

Is it too late to buy Integer Holdings Corporation? How high can it go?

The most bullish analyst target on Integer Holdings Corporation is $127 (+1% above today's price); the average is $112. That's the upside they see. Check how reliable those analysts have actually been on Integer Holdings Corporation on our site before trusting it.

Is Integer Holdings Corporation still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 7 analysts have a real record on Integer Holdings Corporation, the best hitting 59% over 22 calls. Current consensus: "Hold". Make your call on data, not noise.

Should you invest in Integer Holdings Corporation? The case for and against

The arguments for and against, one by one, from the numbers: why invest in ITGR (and why hesitate).

What has Integer Holdings Corporation's past performance been?

Historical returns and a "how much if I had invested" calculator: ITGR performance & returns.

What is the best month to buy ITGR?

The 12 months ranked by the stock's past returns: best & worst month to buy ITGR.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)